Comerica Securities’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-716
Closed -$42.9K 744
2022
Q4
$42.9K Buy
+716
New +$38.9K ﹤0.01% 749
2017
Q3
Sell
-85,212
Closed -$3.3M 400
2017
Q2
$3.3M Buy
85,212
+514
+0.6% +$18.8K 0.49% 48
2017
Q1
$2.88M Buy
84,698
+1,637
+2% +$53.8K 0.45% 58
2016
Q4
$2.73M Sell
83,061
-6,009
-7% -$195K 0.67% 44
2016
Q3
$2.88M Buy
+89,070
New +$2.89M 0.56% 42

Other funds holding EHC

Comerica Securities's EHC Position: Q1 2023 in Review

Comerica Securities sold out of Encompass Health (EHC) in Q1 2023, closing a stake of 716 shares — an estimated $42.9K sold.

Comerica Securities first reported a position in EHC in Q3 2016 and held it in 5 quarters. The position peaked at $3.3M in Q2 2017. 390 funds tracked by Wall St. Rank hold EHC as of Q1 2023.

  • Comerica Securities reported no remaining Encompass Health position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 716 Encompass Health shares in Q1 2023, an estimated $42.9K.
  • Comerica Securities first reported a position in Encompass Health in Q3 2016 and held it in 5 quarters.
  • Comerica Securities's Encompass Health position peaked at $3.3M in Q2 2017.
  • 390 funds tracked by Wall St. Rank held Encompass Health as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.